Exchange: NASDAQ·Updated 04:20 PM EST

BBNX Earnings

Latest Earnings Results: Q3 '26

Reported: Oct 27

Estimated EPS

-$0.52

Reported EPS

-$0.52

Surprise

+0.64%

Estimated Rev

$34.72M

Reported Rev

$35.51M

Surprise

+2.26%

• Reported GAAP EPS of -$0.52 down -57.58% YoY • Reported revenue of $35.51M up 30.31% YoY • Beta Bionics estimates FY2026 total revenue of approximately $124M to $126M, gross margin of 58.5% to 59.5%, and 37% to 39% of new patient starts reimbursed through PBP.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.50
--
--
N/A
Q3 '26
-$0.52
-$0.52
0.64%
BEAT
Q2 '26
-$0.58
-$0.53
8.78%
BEAT
Q1 '26
-$0.50
-$0.49
2.53%
BEAT
Q4 '25
-$0.40
-$0.30
25.59%
BEAT

Advertisement|Remove ads.